Other World Computing (OWC®), a trusted leader in high-performance storage, memory, connectivity, software, and accessories that empower creative and business professionals to maximize performance, enhance reliability, and streamline workflows, today announced an expanded partnership with Hedge. OWC’s Innergize™ software is now integrated into Hedge’s flagship media management and backup application, OffShoot, delivering creative professionals faster, safer, and more reliable workflows. OffSh...

The Seoul Tourism Organization is launching the “Pick 3 Pass,” a new customizable and cost-effective option for its popular Discover Seoul Pass, with official sales beginning on September 15th. This new pass is designed to meet the evolving needs of modern tourists, especially repeat visitors and those seeking a more tailored travel experience, by allowing them to select three attractions of their choice. This press release features multimedia. View the full release here: https://www.businessw...

Via Transportation, Inc. (“Via”), a leading provider of technology to power public transit networks, today announced the launch of its roadshow for the initial public offering of 10,714,285 shares of its Class A common stock. Via is offering 7,142,857 shares of Class A common stock and the selling stockholders are offering 3,571,428 shares of Class A common stock. In connection with the offering, Via is expected to grant the underwriters a 30-day option to purchase up to an additional 1,607,142...

More than 450 new hotels to dream about and book. 12 new countries to travel to with Hilton. A new world of luxury travel. In just one year, Hilton's (NYSE: HLT) exclusive partnership with Small Luxury Hotels of the World (SLH) has grown exponentially, adding on average more than one SLH property every week, dramatically expanding Hilton’s luxury offerings and creating new ways for Hilton Honors members to dream and redeem their Points around the world. This press release features multimedia. ...

Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory milestone makes Embozene the first—and only—embolic agent to be CE Marked specifically for GAE, a minimally invasive procedure intended to target inflammation and help relieve pain in patients with knee osteoarthritis. Knee osteoarthritis is widespread, with a reported prevalence of nearly 375 million c...